Status:
UNKNOWN
Measurement of Anti-dsDNA by Both CLIFT & ELISA
Lead Sponsor:
Assiut University
Conditions:
Antiphospholipid Syndrome
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
detection of anti-ds DNA in patients with rheumatic diseases by two methodes : immunofluorescence \& ELISA
Detailed Description
Autoimmune rheumatic diseases are autoimmune disorders presented with joint and muscles manifestations. However, other organs may be involved at a varying degree in different conditions. They are also...
Eligibility Criteria
Inclusion
- The study will include patients with suspected diagnosis of autoimmune rheumatic diseases referred to the Laboratory of Clinical Immunology, Clinical Pathology Department, Assiut University Hospital for anti-dsDNA test. Patients will be recruited into the study within period of one year.
- Also, apparently healthy subjects (at least 25 subjects; according to international method verification guidelines) will be included as a control group
Exclusion
- Subjects refused to be included in the study. Patients without a definite diagnosis of autoimmune rheumatic disease
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03303508
Start Date
September 1 2018
End Date
October 1 2019
Last Update
October 6 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.